These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26686335)

  • 1. Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization.
    Laffont S; Rolland Y; Ardisson V; Edeline J; Pracht M; Le Sourd S; Rohou T; Lenoir L; Lepareur N; Garin E
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):824-831. PubMed ID: 26686335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personnel dose reduction in
    Law M; Wong KK; Tso WK; Lee V; Luk MY; Tong CC; Chu F
    Br J Radiol; 2017 Mar; 90(1071):20160591. PubMed ID: 27993095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?
    McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB
    J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?
    Gates VL; Hickey R; Marshall K; Williams M; Salzig K; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2038-44. PubMed ID: 26194715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Activity Lost to Delivery-System Residual and Decay in Yttrium-90 Radioembolization.
    Hoang NS; Khalaf MH; Rosenberg JK; Kwofie J; Reposar AL; Wang DS; Louie JD; Sze DY
    J Vasc Interv Radiol; 2018 Dec; 29(12):1672-1677. PubMed ID: 30316674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yttrium-90 Radioembolization in the VX2 Rabbit Model: Radiation Safety and Factors Influencing Delivery Efficiency.
    Gordon AC; Gates VL; White SB; Harris KR; Mouli SK; Kim DH; Omary RA; Salem R; Lewandowski RJ; Larson AC
    J Vasc Interv Radiol; 2021 Nov; 32(11):1569-1574.e11. PubMed ID: 34717835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
    Pasciak AS; Bourgeois AC; Bradley YC
    J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on: "Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization".
    Gates VL; Gabr A; Kallini J; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):822-823. PubMed ID: 26846912
    [No Abstract]   [Full Text] [Related]  

  • 9. Outpatient single-session yttrium-90 glass microsphere radioembolization.
    Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation exposure of the operators in the preparation and administration of yttrium-90 microspheres in the treatment of malignant hepatic lesions: What is the risk?
    Scotognella T; Morasca A; Zagaria L; Capostosti A; Iezzi R; Indovina L; Giordano A; Perotti G
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):293-298. PubMed ID: 34425970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.
    Jia Z; Paz-Fumagalli R; Frey G; Sella DM; McKinney JM; Wang W
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):481-489. PubMed ID: 27826686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex Vivo Evaluation of Residual Activity and Infusion Dynamics in a Commercially Available Yttrium-90 Resin Microsphere Administration System.
    Drescher R; Gühne F; Seifert P; Kühnel C; Freesmeyer M
    J Vasc Interv Radiol; 2019 Sep; 30(9):1504-1511. PubMed ID: 30922798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yttrium-90 Radioembolization with Resin Microspheres without Routine Embolization of the Gastroduodenal Artery.
    Ward TJ; Louie JD; Sze DY
    J Vasc Interv Radiol; 2017 Feb; 28(2):246-253. PubMed ID: 27884683
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
    Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
    Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for 90Y-Resin Microspheres.
    Paprottka KJ; Lehner S; Fendler WP; Ilhan H; Rominger A; Sommer W; Clevert DA; Op den Winkel M; Heinemann V; Paprottka PM
    J Nucl Med; 2016 Nov; 57(11):1679-1684. PubMed ID: 27261516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
    Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
    J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.